Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

Figure 1

Mean visual acuity (in LogMAR) and central foveal thickness (in μm) variations from baseline to the end of follow-up in patients with central (CRVO (a, b)) and branch retinal vein occlusion (BRVO (c, d)). Legend: LogMAR: logarithm of the minimal angle of resolution; FU: follow-up.

(a)

(b)

(c)

(d)